The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

By A. Moeller, K. Ask, D. Warburton, J. Gauldie, M. Kolb. International Journal of Biochemistry and Cell Biology, 2008

990 citations recorded by the source corpus.

Subfields: Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/1ab7239315eaa94d74656aa97c00e405aee89868

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. M. C. Brotons
2. J. Yarnold

Citations in the corpus

• Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment (2010, methodology): “, this model is also used to evaluate potential therapies for pulmonary fibrosi”
• Pathogenetic mechanisms in radiation fibrosis. (2010, background): “Human recombinant protein (rhSAP), entering early phase clinical trials, inhibits bleomycin-induced lung fibrosis in mice, a classical model of lung fibrosis [14,15].”